The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function
Open accessAbstract
The Rho subfamily of small GTP-binding proteins mediates many fundamental cellular functions. The commonly studied members (Rho, Rac, and CDC42) regulate actin reorganization, affecting diverse cellular responses, including adhesion, cytokinesis, and motility. Another major function of the Rho GTPases is their role in regulating transcriptional factors and nuclear signaling. RhoH is encoded by a hematopoiesis-specific Rho-related gene recently identified in a fusion transcript with bcl6 in lymphoma cell lines. Significantly, translocations and a high frequency of RhoH mutation have been detected in primary lymphoma cells. We show here that RhoH functions differently from other Rho GTPases. RhoH exerts no significant effect on actin reorganization. However, RhoH is a potent inhibitor of the activation of NFkappaB and p38 by other Rho GTPases. This property, together with the differential expression of RhoH in the Th1 subset of T cells, suggests a role for RhoH in the functional differentiation of T cells. RhoH has different amino acids in two highly conserved residues critical for GTPase activity. Consequently, RhoH is GTPase deficient, remaining in a GTP-bound activated state without cycling. Reduction of RhoH levels in T cells augments the response to Rac activation. Furthermore, RhoH is dramatically down regulated after phorbol myristate acetate treatment and in Th1 cells after activation by anti-CD3. Hence, a mechanism for regulation of RhoH function is likely to exist at the transcriptional level. The inhibitory function of RhoH supports a model in which Rho GTPases with opposing functions may compete to modulate the final outcome of a particular GTPase-activated pathway.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
RhoH activity is modulated by interaction with other Rho GTPases, transcriptional regulation, or phosphorylation rather than through classical GTPase cycling and effector modulation.
“Its activity is modulated by interaction with other Rho GTPases [19,20], transcriptional regulation [19] or phosphorylation [21] rather than through the classical cycling process and modulation by effector proteins.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Discussion (page unavailable) says RhoH is GTPase deficient, is unlikely to be regulated by nucleotide cycling, and may be regulated through mRNA expression; it also reports evidence of transcriptional regulation. It proposes competition with other Rho GTPases as a model, but does not establish that interaction with them regulates RhoH activity. The statement about phosphorylation is cited to [21], not this source; this paper mentions it only as a possible mechanism and does not establish the claim about effector-protein modulation. (LLM, conf=0.84)
Experimental — accuracy not yet measuredIn a nucleotide dissociation assay, RhoH binds GTP rapidly but does not hydrolyse bound GTP to GDP.
“In a nucleotide dissociation assay it was shown that although RhoH is able to bind GTP rapidly, it does not hydrolyse the bound GTP to GDP [19].”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Results (Fig. 8a–b) report that RhoH binds GTP rapidly and shows no detectable GTP hydrolysis. However, the nucleotide dissociation assay addressed binding and exchange; the lack of hydrolysis was established in a separate GTP hydrolysis assay. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPMA reduces endogenous RhoH transcripts in Jurkat cells after 60-80 min by 80% of baseline, while TNFα treatment does not regulate RhoH mRNA levels.
“Li et al. tested a couple of stimuli on Jurkat cells and reported that PMA reduces endogenous RhoH transcripts after 60–80 min by 80% of the baseline level, while TNFα treatment did not act as a regulator of RhoH mRNA levels [19].”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Results passage (page not provided) reports that PMA reduced endogenous RhoH mRNA in Jurkat cells by at least 80% from baseline at about 60–80 minutes. It also reports little overall change with TNF treatment, but notes a small, consistent transient reduction around 40–60 minutes; the claim's unqualified statement that TNFα did not regulate RhoH mRNA omits that exception. (LLM, conf=0.88)
Experimental — accuracy not yet measuredHigh RhoH amounts suppress IKKβ expression necessary for NFκB activation.
“Initial experiments showed that IKKβ expression that is necessary for NFκB activation is suppressed in the presence of high RhoH amounts, presumably because RhoH inhibits IκB degradation.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Results (Fig. 3b–d) show that higher RhoH doses suppress NFκB activation induced by overexpressed IKKβ, and the Results (Fig. 3e) show retarded IκB degradation. The paper does not show that RhoH suppresses IKKβ expression; it distinguishes inhibition of downstream NFκB activation from inhibition of IKK activity. (LLM, conf=0.88)
Experimental — accuracy not yet measuredRhoH overexpression does not induce activation of p38, JNK or Erk itself, but acts as a specific negative regulator for Rac- and RhoA-induced p38 activity.
“Again, as with NFκB, RhoH overexpression did not induce activation of any of these proteins itself, but rather acted as a specific negative regulator for Rac and RhoA-induced p38 activity.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Results (Fig. 4) show that RhoH expression did not activate p38, JNK, or ERK. The Results (Fig. 5) show that RhoH suppressed Rac1-induced p38 activation, but the RhoA experiment measured NFκB activation, not p38; the p38 experiment tested Rac1 and CDC42. (LLM, conf=0.90)
Experimental — accuracy not yet measured
RhoH reduces RhoA-, Rac1- or Cdc42-induced activation of the transcription factor NFκB.
“RhoH was shown to reduce the RhoA, Rac1 or Cdc42-induced activation of the transcription factor NFκB.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The Results (Fig. 5a) show that RhoH strongly suppressed NFκB activation induced by RhoA and Rac1. The Discussion explicitly says Cdc42-mediated NFκB activation was not tested; its inhibition was proposed as likely, not shown. (LLM, conf=0.94)
Experimental — accuracy not yet measuredRhoH is diffusely distributed in the cytoplasm, and RhoH overexpression causes no difference in morphology of PDGF-stimulated cells.
“The authors describe RhoH to be diffusely distributed in the cytoplasm and they saw no difference in the morphology of PDGF stimulated cells in the presence or absence of RhoH overexpression [19].”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
In Jurkat cells stimulated with TNFα, RhoH decreases NFκB activity.
“Jurkat cells stimulated with TNFα show decreased NFκB activity in the presence of RhoH [19].”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
RhoH is GTPase-deficient.
“Since RhoH is GTPase-deficient, other mechanisms must be available to regulate the activity or function of the protein, one being the possibility of transcriptional regulation.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
The level of RhoH is approximately 3 times higher in the Th1 subset than in the Th2 subset.
“Indeed, the level of RhoH is app. 3 times higher in the Th1 subset.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
RhoGAP p50 does not enable RhoH to hydrolyse GTP.
“The authors investigated whether the RhoGAP p50 which acts as a GAP for RhoA, Rac and Cdc42 might enable RhoH to hydrolyse GTP, but found it not the case.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
RhoH is an atypical Rho GTPase that is constitutively active and not regulated by classical GTP/GDP cycling.
“The haematopoietic GTPase RhoH is an atypical family member of the Rho GTPases as it is constitutively active and not regulated through the classical cycling between GTP- and GDP-bound state.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
Re-stimulation of cells on day 3 using anti-CD3 leads to a decrease of RhoH expression in Th1 cells, whereas no obvious changes occur in Th2 cells.
“Re-stimulation of cells on day 3 using anti-CD3 led to a decrease of RhoH expression in Th1 cells whereas no obvious changes seemed to have occurred in the Th2 cells.”
From The small GTPase RhoH is an atypical regulator of haematopoietic cells (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 3
- [2]2. Adra, C. N., D. Manor, J. L. Ko, S. Zhu, T. Horiuchi, L. Van Aelst, R. A. Cerione, and B. Lim. 1997. RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl. Acad. Sci. USA 94: 4279-4284.
- [32]32. Lelias, J. M., C. N. Adra, G. M. Wulf, J. C. Guillemot, M. Khagad, D. Caput, and B. Lim. 1993. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc. Natl. Acad. Sci. USA 90: 1479-1483.
- [56]56. Sylla, B. S., S. C. Hung, D. M. Davidson, E. Hatzivassiliou, N. L. Malinin, D. Wallach, T. D. Gilmore, E. Kieff, and G. Mosialos. 1998. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF𝛋 B through a pathway that includes the NF𝛋 Binducing kinase and the I 𝛋 B kinases IKK 𝛂 and IKK 𝛃 . Proc. Natl. Acad. Sci. USA 95: 10106-10111.
Cited by
Sorted by citations
The small GTPase RhoH is an atypical regulator of haematopoietic cells
Fueller, F., & Kubatzky, K. F. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-6 · Cited by 40 · see citing works
RhoH GTPase: A Key Regulator of Hematopoietic Cell Proliferation and Apoptosis?
Gu, Y., Zheng, Y., & Williams, D. A. (2005) · Cell Cycle · doi:10.4161/cc.4.2.1395 · Cited by 20 · see citing works
- Authors
- Li, X., Bu, X., Lu, B., Avraham, H., Flavell, R. A., & Lim, B.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Section of Immunobiology
- Howard Hughes Medical Institute (US)
- Corresponding author
- Lim, Bing
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-02
- Volume
- 22
- Issue
- 4
- Pages
- 1158-1171
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC134637
- OpenAlex
- W2135743634
- Cited by
- 153
- References
- 0
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 8 · 2021: 11 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 9 · 2013: 8 · 2012: 5
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK-47535, R01DK054417)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- RhoH, Rho GTPases, hematopoiesis, NF-κB activation, p38 MAPK, actin reorganization, Th1 cells, T cell differentiation, lymphoma, Rac, GTP-bound state, transcriptional regulation
- MeSH terms
- T-Lymphoma Invasion and Metastasis-inducing Protein 1, Amino Acid Sequence, Animals, Cell Line, Cytoskeleton, Gene Expression Regulation, Guanosine Triphosphate, Hematopoiesis, Humans, Molecular Sequence Data, Proteins, Recombinant Fusion Proteins, Transcription Factors, Transfection, Tumor Necrosis Factor-alpha, NF-kappa B, Proto-Oncogene Proteins c-jun, Protein Serine-Threonine Kinases, Genes, Reporter, Guanine Nucleotide Exchange Factors, rho GTP-Binding Proteins, cdc42 GTP-Binding Protein, rac1 GTP-Binding Protein, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review